Clear Harbor Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$7.99M Buy
6,901
+2,299
+50% +$2.71M 0.46% 46
2026
Q2
$5.52M Buy
4,602
+2,586
+128% +$2.64M 0.34% 66
2026
Q1
$1.85M Sell
2,016
-48
-2% -$48.7K 0.13% 132
2025
Q4
$2.22M Sell
2,064
-17
-0.8% -$16.3K 0.15% 114
2025
Q3
$1.59M Buy
2,081
+3
+0.1% +$2.23K 0.11% 150
2025
Q2
$1.62M Sell
2,078
-378
-15% -$294K 0.12% 130
2025
Q1
$2.03M Buy
2,456
+483
+24% +$402K 0.16% 107
2024
Q4
$1.52M Buy
1,973
+1,400
+244% +$1.16M 0.12% 128
2024
Q3
$508K Hold
573
– – 0.04% 236
2024
Q2
$519K Sell
573
-26
-4% -$20.8K 0.04% 216
2024
Q1
$466K Sell
599
-23
-4% -$16.4K 0.04% 233
2023
Q4
$363K Buy
+622
New +$363K 0.03% 260
2020
Q4
– Sell
-372
Closed -$55.1K – 544
2020
Q3
$55.1K Buy
+372
New +$57.6K 0.01% 381
2020
Q1
– Sell
-372
Closed -$48.9K – 506
2019
Q4
$48.9K Buy
+372
New +$43.1K 0.01% 405

Other funds holding LLY

Clear Harbor Asset Management's LLY Position: Q3 2026 in Review

Clear Harbor Asset Management increased its Eli Lilly (LLY) stake by 50% in Q3 2026, buying an estimated $2.71M and bringing the position to 6,901 shares worth $7.99M. The position accounts for 0.46% of the portfolio, ranked #46.

Clear Harbor Asset Management first reported a position in LLY in Q4 2019 and has held it in 14 quarters since. 4,106 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Clear Harbor Asset Management held 6,901 shares of Eli Lilly worth $7.99M as of Q3 2026.
  • Clear Harbor Asset Management bought 2,299 Eli Lilly shares in Q3 2026, an estimated $2.71M.
  • Eli Lilly made up 0.46% of Clear Harbor Asset Management's portfolio in Q3 2026, its #46 holding.
  • Clear Harbor Asset Management first reported a position in Eli Lilly in Q4 2019 and has held it in 14 quarters since.
  • 4,106 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Clear Harbor Asset Management's 13F filing for Q3 2026, filed 5 Nov 2026.